Lynx1 Capital Management LP - 19 May 2025 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
10%+ Owner
Signature
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
Issuer symbol
TCRX
Transactions as of
19 May 2025
Net transactions value
+$3,106,553
Form type
4
Filing time
21 May 2025, 16:49:27 UTC
Previous filing
31 Dec 2024
Next filing
24 Jul 2025

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Lynx1 Capital Management LP 10%+ Owner 151 CALLE DE SAN FRANCISCO, SUITE 200 PMB 1237, SAN JUAN, PUERTO RICO Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member 21 May 2025 0001910456
Nichols Weston 10%+ Owner 151 CALLE DE SAN FRANCISCO, SUITE 200, PMB 1237, SAN JUAN, PUERTO RICO /s/ Weston Nichols 21 May 2025 0001746376

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRX Common stock, $0.0001 par value per share ("Common Stock") Purchase $1,666,553 +1,388,794 +26% $1.20 6,746,141 19 May 2025 See footnote F1
transaction TCRX Common Stock Purchase $1,440,000 +1,200,000 +18% $1.20 7,946,141 20 May 2025 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities to which this filing relates are held directly by Lynx1 Master Fund LP and a managed account to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.